-+ 0.00%
-+ 0.00%
-+ 0.00%

TONIX PHARMACEUTICALS ANNOUNCES LICENSING TNX-4900, A SELECTIVE SIGMA-1 RECEPTOR ANTAGONIST FOR CHRONIC NEUROPATHIC PAIN FROM RUTGERS UNIVERSITY

Reuters·12/16/2025 12:00:01

Please log in to view news